As of 2025-11-28, the Intrinsic Value of Oramed Pharmaceuticals Inc (ORMP) is -2.95 USD. This ORMP valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.85 USD, the upside of Oramed Pharmaceuticals Inc is -203.39%.
Based on its market price of 2.85 USD and our intrinsic valuation, Oramed Pharmaceuticals Inc (ORMP) is overvalued by 203.39%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.95 - -2.95 | -2.95 | -203.39% |
| P/E | (9.99) - (10.77) | (10.39) | -464.4% |
| DDM - Stable | (5.75) - (23.58) | (14.66) | -614.6% |
| DDM - Multi | (4.23) - (13.69) | (6.49) | -327.7% |
| Market Cap (mil) | 116.85 |
| Beta | 0.38 |
| Outstanding shares (mil) | 41.00 |
| Enterprise Value (mil) | 101.05 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.71% |
| Cost of Debt | 5.00% |
| WACC | 6.19% |